Data from three prospective longitudinal human cohorts of prenatal marijuana exposure and offspring outcomes from the fetal period through young adulthood

Gabrielle L McLemore, Kimberlei A Richardson, Gabrielle L McLemore, Kimberlei A Richardson

Abstract

This article includes data from three prospective longitudinal human cohorts of prenatal marijuana exposure (PME) and offspring outcomes from the fetal period through young adulthood. The table herein contains an overview of the major adverse effects associated with PME from the following human cohorts: (1) The Ottawa Prenatal Prospective Study (OPPS); (2) The Maternal Health Practices and Child Development Study (MHPCD); and (3) The Generation R Study (Gen R). In the OPPS, fetal gestational age was measured and age-appropriate standardized neuropsychological instruments were used to assess neonatal responses, and infant-child and adolescent-young adult cognitive and behavioral skills. In the MHPCD, birth length and weight, neonatal body length, and infant-child sleep, cognition, and behavioral parameters were measured. In the Gen R, birth weight and growth were measured, as were infant-child attention and aggression. The data in this article are in support of our report entitled "Prenatal Cannabis Exposure - The "First Hit" to the Endocannabinoid System" (K.A. Richardson, A.K. Hester, G.L. McLemore, 2016) [13].

Keywords: Behavioral skills; Cognitive skills; Fetal period; Maternal Health Practices and Child Development Study (MHPCD); Offspring outcomes; Ottawa Prenatal Prospective Study (OPPS); Prenatal marijuana exposure (PME); Prospective longitudinal human cohorts; Psychological skills; The Generation R Study (Gen R); Young adulthood.

References

    1. Calvigioni D., Hurd Y.L., Harkany T., Keimpema E. Neuronal substrates and functional consequences of prenatal cannabis exposure. Eur. Child Adolesc. Psychiatry. 2014;23(10):931–941. [Epub 2014 May 3. Review. PubMed PMID: 24793873; PubMed Central PMCID: PMC4459494]
    1. Day N.L., Richardson G.A. Prenatal marijuana use: epidemiology, methodologic issues, and infant outcome. Clin. Perinatol. 1991;18(1):77–91. [Review. PubMed PMID: 2040119]
    1. Day N., Sambamoorthi U., Taylor P., Richardson G., Robles N., Jhon Y., Scher M., Stoffer D., Cornelius M., Jasperse D. Prenatal marijuana use and neonatal outcome. Neurotoxicol. Teratol. 1991;13(3):329–334. [PubMed PMID: 1886543]
    1. El Marroun H., Hudziak J.J., Tiemeier H., Creemers H., Steegers E.A., Jaddoe V.W., Hofman A., Verhulst F.C., van den Brink W., Huizink A.C. Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug Alcohol Depend. 2011;118(2-3):470–474. [Epub 2011 Apr 5. PubMed PMID: 21470799]
    1. El Marroun H., Tiemeier H., Steegers E.A., Jaddoe V.W., Hofman A., Verhulst F.C., vanden Brink W., Huizink A.C. Intrauterine cannabis exposure affects fetal growth trajectories: the generation R study. J. Am. Acad. Child Adolesc. Psychiatry. 2009;48(12):1173–1181. [PubMed PMID: 19858757]
    1. Fried P.A. Marihuana use by pregnant women: neurobehavioral effects in neonates. Drug Alcohol Depend. 1980;6(6):415–424. [PubMed PMID: 7472153]
    1. Fried P.A., Watkinson B. 12- and 24-month neurobehavioural follow-up of children prenatally exposed to marihuana, cigarettes and alcohol. Neurotoxicol. Teratol. 1988;10(4):305–313. [PubMed PMID: 3226373]
    1. Fried P.A., Watkinson B., Gray R. Differential effects on cognitive functioning in 9- to 12-year olds prenatally exposed to cigarettes and marihuana. Neurotoxicol. Teratol. 1998;20(3):293–306. [PubMed: 9638687]
    1. Hofman A., Jaddoe V.W., Mackenbach J.P., Moll H.A., Snijders R.F., Steegers E.A., Verhulst F.C., Witteman J.C., Büller H.A. Growth, development and health from early fetal life until young adulthood: the Generation R Study. Paediatr. Perinat. Epidemiol. 2004;18(1):61–72. [PubMed PMID: 14738548]
    1. Huizink A.C. Prenatal cannabis exposure and infant outcomes: overview of studies. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2014;52:45–52. [Epub 2013 Sep 27. Review. PubMed PMID: 24075896]
    1. Jaddoe V.W., van Duijn C.M., van der Heijden A.J., Mackenbach J.P., Moll H.A., Steegers E.A., Tiemeier H., Uitterlinden A.G., Verhulst F.C., Hofman A. The generation R study: design and cohort update 2010. Eur. J. Epidemiol. 2010;25(11):823–841. [Epub 2010 Oct 22. PubMed PMID: 20967563; PubMed Central PMCID: PMC2991548]
    1. Jaddoe V.W., van Duijn C.M., Franco O.H., van der Heijden A.J., van Iizendoorn M.H., de Jongste J.C., van der Lugt A., Mackenbach J.P., Moll H.A., Raat H., Rivadeneira F., Steegers E.A., Tiemeier H., Uitterlinden A.G., Verhulst F.C., Hofman A. The generation R study: design and cohort update 2012. Eur. J. Epidemiol. 2012;27(9):739–756. [Epub 2012 Oct 20. PubMed PMID: 23086283]
    1. Richardson K.A., Hester A.K., McLemore G.L. Prenatal cannabis exposure - The "First Hit" to the endocannabinoid system. Neurotoxicol. Teratol. 2016 [Epub ahead of print][Review. PubMed PMID: 27567698]
    1. Verbruggen F., Logan G.D. Response inhibition in the stop-signal paradigm. Trends Cogn. Sci. 2008;12(11):418–424. [Review. PubMed PMID: 18799345; PubMed Central PMCID: PMC2709177]
    1. Wu C.S., Jew C.P., Lu H.C. Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. Future Neurol. 2011;6(4):459–480. [PubMed PMID: 22229018; PubMed Central PMCID: PMC3252200]

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다